BRUNELLI, Matteo
 Distribuzione geografica
Continente #
NA - Nord America 11.723
EU - Europa 11.037
AS - Asia 3.390
OC - Oceania 25
SA - Sud America 24
Continente sconosciuto - Info sul continente non disponibili 12
AF - Africa 9
Totale 26.220
Nazione #
US - Stati Uniti d'America 11.495
GB - Regno Unito 4.165
CN - Cina 3.091
IT - Italia 1.535
SE - Svezia 1.341
IE - Irlanda 1.065
FR - Francia 927
DE - Germania 884
FI - Finlandia 604
CA - Canada 221
UA - Ucraina 206
BE - Belgio 100
VN - Vietnam 93
RU - Federazione Russa 86
TR - Turchia 68
NL - Olanda 28
IN - India 23
AU - Australia 22
IR - Iran 21
HK - Hong Kong 18
AT - Austria 14
ES - Italia 12
JP - Giappone 12
SG - Singapore 12
CL - Cile 11
EU - Europa 8
PL - Polonia 8
LV - Lettonia 7
TW - Taiwan 7
CH - Svizzera 6
CZ - Repubblica Ceca 6
BG - Bulgaria 5
BR - Brasile 5
HU - Ungheria 5
IL - Israele 5
PK - Pakistan 5
EG - Egitto 4
GR - Grecia 4
ID - Indonesia 4
IM - Isola di Man 4
PT - Portogallo 4
RO - Romania 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CO - Colombia 3
KG - Kirghizistan 3
KR - Corea 3
MT - Malta 3
MX - Messico 3
NZ - Nuova Zelanda 3
PH - Filippine 3
AL - Albania 2
AM - Armenia 2
BD - Bangladesh 2
CM - Camerun 2
EE - Estonia 2
LA - Repubblica Popolare Democratica del Laos 2
MK - Macedonia 2
MY - Malesia 2
NO - Norvegia 2
PA - Panama 2
PE - Perù 2
SA - Arabia Saudita 2
TH - Thailandia 2
A1 - Anonimo 1
AR - Argentina 1
BO - Bolivia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
HR - Croazia 1
JO - Giordania 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
ME - Montenegro 1
RS - Serbia 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TM - Turkmenistan 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 26.220
Città #
Southend 3.738
Chandler 2.472
Jacksonville 1.328
Woodbridge 1.067
Dublin 1.055
Ann Arbor 960
Beijing 660
Ashburn 612
Houston 447
Lawrence 367
Princeton 367
New York 349
Wilmington 345
Jinan 330
Verona 290
Nanjing 244
Shenyang 224
Helsinki 216
Montréal 195
Munich 182
Mcallen 179
Hebei 175
Sindelfingen 134
Dearborn 131
Tianjin 129
Zhengzhou 119
Redmond 118
Ningbo 102
Brussels 97
Taizhou 93
Changsha 92
Seattle 91
Bologna 86
Haikou 86
Nanchang 79
Redwood City 74
Milan 72
Guangzhou 69
Taiyuan 69
Lancaster 66
Jiaxing 65
Hangzhou 62
Dong Ket 57
Rome 54
Norwalk 51
Volga 47
Fairfield 38
Lanzhou 37
Washington 34
Boardman 33
Chicago 33
Detroit 33
Falls Church 29
Düsseldorf 28
Fuzhou 27
San Francisco 23
Augusta 19
Dongguan 19
San Mateo 16
Palermo 14
Vienna 14
Cambridge 13
Toronto 13
Bari 12
Ardabil 11
Lappeenranta 11
Clearwater 10
Hong Kong 10
Isola della Scala 10
Perugia 10
Pozza 10
Singapore 10
Bolzano 9
Los Angeles 9
Groningen 8
Leawood 8
Nürnberg 8
Qingdao 8
Riva 8
San Diego 8
Wuhan 8
Berlin 7
Chions 7
Frankfurt am Main 7
Saint Louis 7
Shanghai 7
Torino 7
Trento 7
Buffalo 6
Canberra 6
Grezzana 6
Legnaro 6
Pisa 6
San Donà Di Piave 6
Sydney 6
Tappahannock 6
Turin 6
Yicheng 6
York 6
Atlanta 5
Totale 18.556
Nome #
ARFI Evaluation of Small (<4 cm) Renal Masses. A Preliminary Study 804
I tumori ibridi nell'oncocitosi renale sono l'anello di congiunzione tra oncocitoma renale e il carcinoma renale di tipo cromofobo? 426
Instabilità dei microsatelliti nei carcinomi duttali e nei tumori endocrini del pancreas 283
A re-emerging marker for prognosis in hepatocellular carcinoma: the add-value of fishing c-myc gene for early relapse. 151
Analisi citogenetica in metafase ed interfase nel carcinoma renale cromofobo e nell'onocitoma del rene 143
True 3q Chromosomal Amplification in Squamous Cell Lung Carcinoma by FISH and aCGH Molecular Analysis: Impact on Targeted Drugs 143
Comprehensive molecular portrait using next generation sequencing of resected intestinal-type gastric cancer patients dichotomized according to prognosis 139
Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study 134
Breast cancer with both assessment of Her2/Neu overexpression and gene amplification:clinical impact in selecting patients for drug treatment 131
LC3B and ph-S6K are both expressed in epithelioid and classic renal angiomyolipoma: a rationale tissue-based evidence for combining use of autophagic and mTOR targeted drugs 131
Schwannoma del rene 130
Utilità diagnostica della valutazione della ploidia con citometria a flusso nella diagnosi differenziale delle neoplasie a cellule renali 128
A clinical-biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status 127
Clinical Factors Predicting and Stratifying the Risk of Lymph Node Invasion in Localized Prostate Cancer 121
Chondroid syringoma with extensive ossification 118
Low-Risk Prostate Cancer and Tumor Upgrading to Higher Patterns in the Surgical Specimen. Analysis of Clinical Factors Predicting Tumor Upgrading to Higher Gleason Patterns in a Contemporary Series of Patients Who Have Been Evaluated According to the Modified Gleason Score Grading System 117
An unusual case of Cushing's syndrome due to ACTH-independent macronodular adrenal hyperplasia 115
Adrenal extramedullary hematopoiesis: report on a pediatric case and update of the literature. 114
Impact of neoadjuvant single or dual HER2 inhibition and chemotherapy backbone upon pathological complete response in operable and locally advanced breast cancer: Sensitivity analysis of randomized trials 114
L'ESPRESSIONE DI CITOCHERATINE E' IN ACCORDO CON LA DIFFERENZIAZIONE EPITELIALE DELLE NEOPLASIE RENALI HMB45 POSITIVE CON TRASLOCAZIONE T(6;11) 113
ALK gene copy number in lung cancer: Unspecific polyploidy versus specific amplification visible as double minutes 113
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers 111
Carcinomi con traslocazioni coinvolgenti i geni della famiglia MiTF/TFE. 110
Carcinoma a cellule renali associato ad evidente proliferazione stromale leiomiomatosa 109
RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes 108
Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study 107
Acquired hemophagocytic syndrome in a patient with synovial sarcoma: a case report 107
CD10 is expressed in a subset of chromophobe renal cell carcinomas 106
ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations 104
Adult primary teratoma of the testis--report on 5 cases in clinical stage I disease. 103
Utilità diagnostica di CD13 e CD10 nelle neoplasie a cellule renali 103
Subepithelial haematoma of the renal pelvis (Antopol-Goldman lesion) 103
Oncocytic papillary renal cell carcinoma: potential pitfall in small enucleation. 101
Digital reporting of whole-slide images is safe and suitable for assessing organ quality in preimplantation renal biopsies 101
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 101
Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 338 patients with conventional renal cell carcinoma 100
FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma. 99
Monosomy of chromosome 17 in breast cancer during interpretation of HER2 gene amplification 99
The preoperative serum ratio of total prostate specific antigen (PSA) to free testosterone (FT), PSA/FT index ratio, and prostate cancer. Results in 220 patients undergoing radical prostatectomy 99
Neoadjuvant strategies for triple negative breast cancer: 'state-of-the-art' and future perspectives 98
HER2/neu Gene Determination in Women Screened for Breast Carcinoma: How Screening Programs Reduce the Skyrocketing Cost of Targeted Therapy 97
Donor kidneys with miliary papillary renal cell neoplasia: the role of the pathologist in determining suitability for transplantation 97
Clinical Factors of Disease Reclassification or Progression in a Contemporary Cohort of Prostate Cancer Patients Elected to Active Surveillance 97
Mesothelial/monocytic incidental cardiac excrescences (MICE): report of a case and review of literature with focus on pathogenesis 97
The identification of a small but significant subset of patients still targetable with anti-HER2 inhibitors when affected by triple negative breast carcinoma 97
The incidence and relative risk of pulmonary toxicity in patients treated with anti-PD1/PD-L1 therapy for solid tumors: a meta-analysis of current studies 97
De Novo Renal Neoplasia After Kidney Transplantation According to New 2016 WHO Classification of Renal Tumors 97
Carcinoma a cellule renali di tipo papillare a cellule oncocitiche: studio clinico-patologico di 10 casi. 96
iPathology cockpit diagnostic station: validation according to College of American Pathologists Pathology and Laboratory Quality Center recommendation at the Hospital Trust and University of Verona 96
Clinical factors stratifying the risk of tumor upgrading to high-grade disease in low-risk prostate cancer 96
Prognostic impact of proliferation for resected early stage 'pure' invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validation 96
Bilateral lymph node micrometastases and seminal vesicle invasion associated with same clinical predictors in localized prostate cancer 96
Molecular heterogeneity assessment by next-generation sequencing and response to gefitinib of EGFR mutant advanced lung adenocarcinoma 94
Preoperative plasma levels of total testosterone associated with high grade pathology-detected prostate cancer: preliminary results of a prospective study in a contemporary cohort of patients 94
ALK/EML4 Fusion Gene May Be Found in Pure Squamous Carcinoma of the Lung 94
Reprofiling Metastatic Samples for Chromosome 9p and 14q Aberrations as a Strategy to Overcome Tumor Heterogeneity in Clear-cell Renal Cell Carcinoma 93
Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of Ki67 assay according to histology: prognostic relevance for resected early stage 'pure' and 'mixed' lobular breast cancer 93
Next-generation repeat-free FISH probes for DNA amplification in glioblastoma in vivo: Improving patient selection to MDM2-targeted inhibitors 93
CARCINOMI DELLA MAMMELLA POSITIVI ALL'IMMUNOESPRESSIONE PER HER-2: VALUTAZIONE CON METODICA FISH DEI CASI CON IMMUNOESPRESSIONE INTRATUMORALE ETEROGENEA 92
Investigating BRCA Mutations: A Breakthrough in Precision Medicine of Castration-Resistant Prostate Cancer 92
The Tumor Entity Denominated "clear cell-papillary renal cell carcinoma" According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome 92
Oncogene-induced senescence distinguishes indolent from aggressive forms of pulmonary and non-pulmonary Langerhans cell histiocytosis 92
Rapid screening for malignancy in organ donors. 15 years experience with the Verona "Alert" protocol and review of the literature 92
Espressione di CD23 nelle neoplasie cutanee annessiali 91
Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors. 91
Prostate Volume Index Associates with a Decreased Risk of Prostate Cancer: Results of a Large Cohort of Patients Elected to a First Biopsy Set 91
Parvalbumin is constantly expressed in chromophobe renal carcinoma. 90
Adenocarcinoma of the paraurethral glands: a case report 90
Fast Chromotrope Aniline Blue Special Stain Is a Useful Tool to Assess Fibrosis on Liver Biopsy During Transplantation 90
Intraprostatic chronic inflammation is associated with a reduced risk of prostate cancer in patients elected to a first random biopsy set 88
Extranodal extension of lymph node metastasis influences recurrence in prostate cancer: a systematic review and meta-analysis 88
Her-2/neu evaluation in Sister Mary Joseph's nodule from breast carcinoma: a case report and review of the literature 88
Genotypic Intratumoral Heterogeneity in Breast Carcinoma with HER2/neu Amplification Evaluation According to ASCO/CAP Criteria 87
Break-apart interphase fluorescence in situ hybridization assay in papillary thyroid carcinoma: on the road to optimizing the cut-off level for RET/PTC rearrangements 87
8C.05: EPOXYEICOSATRIENOIC ACIDS ARE INCREASED IN PLACENTAS OF PREECLAMPTIC PREGNANCIES 87
Wide spetcrum mutational analysis of metastatic renal cell cancer: a retrospective next generation sequencing approach 87
Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the Bladder 87
Targeting Met and VEGFR Axis in Metastatic Castration-Resistant Prostate Cancer: 'Game Over'? 87
[Diagnostic and prognostic markers in renal tumors] 86
A distinctive translocation carcinoma of the kidney; "rosette forming," t(6;11), HMB45-positive renal tumor: a histomorphologic, immunohistochemical, ultrastructural, and molecular genetic study of 4 cases 86
Sirolimus and Everolimus Pathway: Reviewing Candidate Genes Influencing Their Intracellular Effects 86
Ependymoma with diffuse signet-ring features: report of a case and review of the literature 86
Cathepsin-k as a diagnostic marker in the identification of micro-granulomas in Crohn's disease 86
Increased epoxyeicosatrienoic acids and reduced soluble epoxide hydrolase expression in the preeclamptic placenta 86
Predictive and Prognostic Role of Tumor-Infiltrating Lymphocytes for Early Breast Cancer According to Disease Subtypes: Sensitivity Analysis of Randomized Trials in Adjuvant and Neoadjuvant Setting 86
Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Heat Shock Protein 90 Overexpression, Ki67 Proliferative Index, and Topoisomerase II-α Co-amplification as Predictors of Pathologic Complete Response to Neoadjuvant Chemotherapy With Trastuzumab and Docetaxel 86
Chromosomal gains in the sarcomatoid transformation of chromophobe renal cell carcinoma 85
Pediatric optic nerve sheath meningioma 85
High Testosterone Preoperative Plasma Levels Independently Predict Biopsy Gleason Score Upgrading in Men with Prostate Cancer Undergoing Radical Prostatectomy 85
Addressing the best treatment for non-clear cell renal cell carcinoma: A meta-analysis of randomised clinical trials comparing VEGFR-TKis versus mTORi-targeted therapies 85
t(6;11) renal cell carcinoma: a study of seven cases including two with aggressive behavior, and utility of CD68 (PG-M1) in the differential diagnosis with pure epithelioid PEComa/epithelioid angiomyolipoma 85
Current and developing therapies for the treatment of non-small cell lung cancer with ALK abnormalities: update and perspectives for clinical practice 85
Is a Drain Needed after Robotic Radical Prostatectomy with or without Pelvic Lymph Node Dissection? Results of a Single-Center Randomized Clinical Trial 85
Loss of chromosome 9p is an independent prognostic factor in patients with clear cell renal cell carcinoma 84
Significato prognostico della perdita del cromosoma 9P nei carcinomi renali a cellule chiare stratificati per UISS e SSIGN score 84
Acquired cystic disease-associated renal tumors: an immunohistochemical and fluorescence in situ hybridization study 83
Role of molecular markers in diagnosis and prognosis of renal cell carcinoma 83
HER-2/neu assessment in breast cancer using the original FDA and new ASCO/CAP guideline recommendations: impact on selecting patients for herceptin therapy 82
Diagnostic usefulness of fluorescent cytogenetics in differentiating chromophobe renal cell carcinoma from renal oncocytoma: a validation study combining metaphase and interphase analyses 82
Carcinoma renale a cellule chiare papillare: una distinta entità istopatologica e genetica 82
Totale 11.136
Categoria #
all - tutte 84.716
article - articoli 75.288
book - libri 0
conference - conferenze 9.249
curatela - curatele 0
other - altro 179
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 169.432


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019417 0 0 0 0 0 0 0 0 0 30 147 240
2019/20203.286 356 66 44 223 296 447 400 181 177 333 308 455
2020/20213.742 351 616 231 540 534 355 105 150 124 62 416 258
2021/20223.076 333 739 51 338 150 132 50 208 93 85 232 665
2022/20237.040 459 772 615 1.188 606 1.737 72 482 765 72 162 110
2023/20243.030 172 300 332 447 481 669 199 246 67 117 0 0
Totale 27.024